IMPAX Laboratories, Inc. Acquires Rights to Abbreviated New Drug Applications From Watson Laboratories, Inc. And Cobalt Laboratories
HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced it acquired Abbreviated New Drug Applications (ANDA) from Watson Pharmaceuticals and Cobalt Laboratories, a subsidiary of Arrow Group.